Literature DB >> 8354290

Teichoic acid and lipoteichoic acid of Streptococcus pneumoniae possess identical chain structures. A reinvestigation of teichoid acid (C polysaccharide).

W Fischer1, T Behr, R Hartmann, J Peter-Katalinić, H Egge.   

Abstract

Teichoic acid (C polysaccharide) was extracted and purified from Streptococcus pneumoniae R6 with standard procedures except that lipoteichoic acid was extracted first. The dephosphorylated repeating unit was isolated after hydrolysis with 48% (by mass) HF, the bis(phosphocholine)-containing repeating unit was isolated by alkali hydrolysis, anion-exchange chromatography and phosphomonoester cleavage. On the basis of compositional analysis, fast-atom-bombardment mass spectrometry and NMR spectroscopy the following structure is proposed: [formula: see text] where AATGal is 2-acetamido-4-amino-2,4,6-trideoxy-D-galactose. The repeating units are linked to each other by phosphodiester bonds between O5 of the ribitol and O6 of the glucopyranosyl residue of adjacent units. This chain structure is identical with that previously established for pneumococcal lipoteichoic acid [Behr, T., Fischer, W., Peter-Katalinić, J. & Egge, H. (1992) Eur. J. Biochem. 207, 1063-1075]. This represents a unique situation because in other Gram-positive bacteria teichoic and lipoteichoic acids are structurally unrelated.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8354290     DOI: 10.1111/j.1432-1033.1993.tb18102.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  58 in total

1.  The licC gene of Streptococcus pneumoniae encodes a CTP:phosphocholine cytidylyltransferase.

Authors:  C O Rock; R J Heath; H W Park; S Jackowski
Journal:  J Bacteriol       Date:  2001-08       Impact factor: 3.490

2.  Antibody-enhanced pneumococcal adherence requires IgA1 protease.

Authors:  Jeffrey N Weiser; Deborah Bae; Claudine Fasching; Ronald W Scamurra; Adam J Ratner; Edward N Janoff
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-17       Impact factor: 11.205

Review 3.  Properties and biological role of streptococcal fratricins.

Authors:  Kari Helene Berg; Truls Johan Biørnstad; Ola Johnsborg; Leiv Sigve Håvarstein
Journal:  Appl Environ Microbiol       Date:  2012-03-09       Impact factor: 4.792

Review 4.  Envelope Structures of Gram-Positive Bacteria.

Authors:  Mithila Rajagopal; Suzanne Walker
Journal:  Curr Top Microbiol Immunol       Date:  2017       Impact factor: 4.291

5.  Mechanisms in the serotype-independent pneumococcal immunity induced in mice by intranasal vaccination with the cell wall polysaccharide.

Authors:  Ying-Jie Lu; Ian Chr Skovsted; Claudette M Thompson; Porter W Anderson; Richard Malley
Journal:  Microb Pathog       Date:  2009-07-03       Impact factor: 3.738

6.  Antiphosphorylcholine antibody levels are elevated in humans with periodontal diseases.

Authors:  H A Schenkein; J C Gunsolley; A M Best; M T Harrison; C L Hahn; J Wu; J G Tew
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

7.  Decoration of lipopolysaccharide with phosphorylcholine: a phase-variable characteristic of Haemophilus influenzae.

Authors:  J N Weiser; M Shchepetov; S T Chong
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

8.  Generation and properties of a Streptococcus pneumoniae mutant which does not require choline or analogs for growth.

Authors:  J Yother; K Leopold; J White; W Fischer
Journal:  J Bacteriol       Date:  1998-04       Impact factor: 3.490

9.  Evaluation of pneumococcal polysaccharide immunoassays using a 22F adsorption step with serum samples from infants vaccinated with conjugate vaccines.

Authors:  Jan T Poolman; Carl E Frasch; Helena Käyhty; Pascal Lestrate; Shabir A Madhi; Isabelle Henckaerts
Journal:  Clin Vaccine Immunol       Date:  2009-11-04

10.  Synthesis of CDP-activated ribitol for teichoic acid precursors in Streptococcus pneumoniae.

Authors:  Stefanie Baur; Jon Marles-Wright; Stephan Buckenmaier; Richard J Lewis; Waldemar Vollmer
Journal:  J Bacteriol       Date:  2008-12-12       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.